NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+7.25%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$613M
AUM Growth
+$613M
(+16%)
Cap. Flow
+$11.9M
Cap. Flow
% of AUM
1.94%
Top 10 Holdings %
Top 10 Hldgs %
59.83%
Holding
66
New
9
Increased
15
Reduced
10
Closed
4
Top Buys
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
$60.6M |
| 2 |
AFI
Armstrong Flooring, Inc.
AFI
|
$14.5M |
| 3 |
ENT
Global Eagle Entertainment Inc.
ENT
|
$11.5M |
| 4 |
JMBA
Jamba, Inc.
JMBA
|
$7.36M |
| 5 |
Luxfer Holdings
LXFR
|
$7.34M |
Top Sells
| 1 |
YHOO
Yahoo Inc
YHOO
|
$44.1M |
| 2 |
SCLN
Sciclone Pharmaceuticals Inc
SCLN
|
$18.5M |
| 3 |
FirstCash
FCFS
|
$15.9M |
| 4 |
Citi Trends
CTRN
|
$8.41M |
| 5 |
ZVO
Zovio Inc. Common Stock
ZVO
|
$8.16M |
Sector Composition
| 1 | Financials | 27.14% |
| 2 | Healthcare | 16.58% |
| 3 | Technology | 13.76% |
| 4 | Industrials | 13.09% |
| 5 | Consumer Discretionary | 12.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCLN
51
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| – | – |
-1,891,328
| Closed | -$18.5M |
|
|
SNAK
52
DELISTED
Inventure Foods, Inc.
SNAK
| – | – |
-208,181
| Closed | -$920K |
|
|
AVXS
53
DELISTED
AveXis, Inc. Common Stock
AVXS
| – | – |
0
| – | – |
|
|
SHLD
54
DELISTED
Sears Holding Corporation
SHLD
| – | – |
0
| – | – |
|
|
MDCO
55
DELISTED
Medicines Co
MDCO
| – | – |
0
| – | – |
|
|
HTZ
56
DELISTED
Hertz Global Holdings, Inc.
HTZ
| – | – |
0
| – | – |
|
57
Stellantis
STLA
$26.4B
| – | – |
0
| – | – |
|
58
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
59
RH
RH
$4.14B
| – | – |
0
| – | – |
|
60
PetMed Express
PETS
$62.6M
| – | – |
0
| – | – |
|
61
Light & Wonder
LNW
$7.16B
| – | – |
-220,675
| Closed | -$5.22M |
|
62
SPDR S&P Regional Banking ETF
KRE
$3.97B
| – | – |
0
| – | – |
|
63
iShares Russell 2000 ETF
IWM
$66.6B
| – | – |
0
| – | – |
|
64
GameStop
GME
$10.2B
| – | – |
0
| – | – |
|
65
Exact Sciences
EXAS
$9.33B
| – | – |
0
| – | – |
|